Winston Pharmaceuticals, Inc.
100 North Fairway Drive
Suite 134
Vernon Hills,
IL 60061
United States - Map
Phone: 847-362-8200
Web Site: http://www.winstonlabs.com
| Winston Pharmaceuticals, Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of pain-management products primarily in the United States. Its product candidates span a range of pain indications, including osteoarthritis, neuropathic pain, cancer pain, post-surgical pain, episodic cluster headache, and chronic daily headache. The companys flagship compound is Civamide, a TRPV-1 (transient receptor potential vanilloid-1) receptor modulator, which depresses the activity of the type-C pain fibers. Its product also includes doxepin hydrochloride, a Phase IIa completed for prophylaxis and the treatment of chronic daily headache. The company was founded in 1992 and is headquartered in Vernon Hills, Illinois. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Jeffrey R. Bernstein Ph.D.,
Chief Exec. Officer and Pres |
$
1.00K | N/A | Dr. Joel E. Bernstein M.D., 66
Founder |
$
267.00K | N/A | Mr. David Starr , 39
Chief Financial Officer, Principal Accounting Officer, VP and Sec. |
$
214.00K | N/A | Dr. Scott B. Phillips M.D., 48
Sr. VP of Scientific Affairs |
$
235.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
Profile
